Champions Oncology (CSBR) Gross Margin Growth (1y) (2011 - 2026)
Champions Oncology (CSBR) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
526.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-5.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Champions Oncology |
91.38 Mn |
84.37 Mn |
13.89 Mn |
2,273.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
2,273.00 |
| Oct 31, 2025 |
677.00 |
| Jul 31, 2025 |
3,704.00 |
| Apr 30, 2025 |
-16,660.00 |
| Jan 31, 2025 |
-2,388.00 |
| Oct 31, 2024 |
212.00 |
| Jul 31, 2024 |
1,088.00 |
| Apr 30, 2024 |
16,389.00 |
| Jan 31, 2024 |
-116.00 |
| Oct 31, 2023 |
-507.00 |
| Jul 31, 2023 |
-987.00 |
| Apr 30, 2023 |
9,039.00 |
| Jan 31, 2023 |
-205.00 |
| Oct 31, 2022 |
-3,820.00 |
| Jul 31, 2022 |
-335.00 |
| Apr 30, 2022 |
-13,259.00 |
| Jan 31, 2022 |
206.00 |
| Oct 31, 2021 |
4,187.00 |
| Jul 31, 2021 |
-3,530.00 |
| Apr 30, 2021 |
-10,214.00 |
